Adrenaline for the Treatment of No-Reflow in Normotensive Patients

NCT04699110 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

201

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
No-Reflow Phenomenon
Normotensive

Interventions

DRUG: Adrenaline
DRUG: Adenosine

Sponsor

National Institute of Cardiovascular Diseases, Pakistan